Condition: Temporomandibular Disorder · Sponsor: Region Stockholm
Both patients and remitters ask for treatment with Botulinumtoxin A (BTX) with the hope that it will be an effective aid for pain, but little is known regarding if the effect is dose dependent. The aim of this project is to investigate if injections with BTX in the masseter- and temporal muscle is an efficient treatment in patient with myogenous temporomandibular disorders (TMD) and if the effect of BTX is dose dependent.
This description comes directly from the study's public registry record.
Veronica de Flon · + 46 702182623 · veronica.deflon@regionstockholm.se
Hajer Jasim · hajer.jasim@reigionstockholm.se
Always discuss trial participation with your own doctor first.
| Eastman institute Folktandvården Region Stockholm | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06941636